Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

B2B sales

AstraZeneca AZ

AZ sells Zurampic rights to Gruenenthal for $230m

Continues to sell off unwanted assets in order to focus resources and meet $45bn sales target

Brain cancer glioblastoma

Tension expected as cancer market rises to $150bn-plus

IMS Health report anticipates increased demand for value-based pricing of oncology drugs

- PMLiVE

Cell Medica adds to senior management team

Alain Pralong and Stefanos Theoharis join

- PMLiVE

The human perspective

Boehringer’s HR lead Andreas Neumann on the company’s strategic changes and the role of company culture

- PMLiVE

Roche picks up European rights to diabetes implant

Will distribute Senseonics' Eversense CGM System in Germany, Italy and the Netherlands

- PMLiVE

The Creative Floor Healthcare Awards finalists announced

11-London, Concentric and Havas Just are among those shortlisted

Biomarin

BioMarin gives up on muscular dystrophy drug

Makes ‘difficult but necessary’ decision to abandon exon-skipping therapy Kyndrisa

- PMLiVE

GSK brings forward triple COPD therapy filing in US

Intends to file the three-drug respiratory therapy by the end of 2016

Jennifer Herron appointed as chief commercial officer of ARIAD

She brings experience from Bristol-Myers Squibb and Novartis

- PMLiVE

Sanofi Genzyme launches multiple sclerosis awareness campaign

Aims to highlight and address the physical and emotional burden of the disease

First things first: How to kick-off an e-detailing project

Starting a new e-detailing project? Here are our tips to set a solid base for it

Anthill Agency

EU flag

Imbruvica wins wider European leukaemia licence

AbbVie and J&J’s first-in-class drug now approved to treat all CLL patients in the EU

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links